Ra Capital Healthcare Fund Lp - Net Worth and Insider Trading
Ra Capital Healthcare Fund Lp Net Worth
The estimated net worth of Ra Capital Healthcare Fund Lp is at least $3.5 Billion dollars as of 2024-07-05. Ra Capital Healthcare Fund Lp is the 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion. Ra Capital Healthcare Fund Lp is the 10% Owner of Vaxcyte Inc and owns about 5,001,593 shares of Vaxcyte Inc (PCVX) stock worth over $381 Million. Ra Capital Healthcare Fund Lp is also the Director, 10% Owner of Janux Therapeutics Inc and owns about 9,165,652 shares of Janux Therapeutics Inc (JANX) stock worth over $353 Million. Besides these, Ra Capital Healthcare Fund Lp also holds Eidos Therapeutics Inc (EIDX) , Ra Pharmaceuticals Inc (RARX) , Forma Therapeutics Holdings Inc (FMTX) , Rhythm Pharmaceuticals Inc (RYTM) , WAVE Life Sciences Ltd (WVE) , Icosavax Inc (ICVX) , Achillion Pharmaceuticals Inc (ACHN) , Arvinas Inc (ARVN) , Fulcrum Therapeutics Inc (FULC) , Cytek Biosciences Inc (CTKB) , DICE Therapeutics Inc (DICE) , Acumen Pharmaceuticals Inc (ABOS) , Phathom Pharmaceuticals Inc (PHAT) , Akouos Inc (AKUS) , Solid Biosciences Inc (SLDB) , LENZ Therapeutics Inc (LENZ) , Imara Inc (IMRA) , G1 Therapeutics Inc (GTHX) , Orchard Therapeutics PLC (ORTX) , Mineralys Therapeutics Inc (MLYS) , Black Diamond Therapeutics Inc (BDTX) , AN2 Therapeutics Inc (ANTX) , scPharmaceuticals Inc (SCPH) , Therapeutics Acquisition Corp (RACA) , ARS Pharmaceuticals Inc (SPRY) , Tyra Biosciences Inc (TYRA) , Elevance Health Inc (ANTX) , Eliem Therapeutics Inc (ELYM) , Satsuma Pharmaceuticals Inc (STSA) , Nkarta Inc (NKTX) , Verastem Inc (VSTM) , PepGen Inc (PEPG) , Acrivon Therapeutics Inc (ACRV) , 89bio Inc (ETNB) , Vor Biopharma Inc (VOR) , Boundless Bio Inc (BOLD) , Kala Bio Inc (KALA) , Werewolf Therapeutics Inc (HOWL) , Aerovate Therapeutics Inc (AVTE) . Details can be seen in Ra Capital Healthcare Fund Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ra Capital Healthcare Fund Lp has not made any transactions after 2024-06-27 and currently still holds the listed stock(s).
Transaction Summary of Ra Capital Healthcare Fund Lp
Ra Capital Healthcare Fund Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ra Capital Healthcare Fund Lp owns 56 companies in total, including Vaxcyte Inc (PCVX) , 89bio Inc (ETNB) , and Rhythm Pharmaceuticals Inc (RYTM) among others .
Click here to see the complete history of Ra Capital Healthcare Fund Lp’s form 4 insider trades.
Insider Ownership Summary of Ra Capital Healthcare Fund Lp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PCVX | Vaxcyte Inc | 2020-10-08 | 10 percent owner |
ETNB | 89bio Inc | 2024-03-04 | director & 10 percent owner |
RYTM | Rhythm Pharmaceuticals Inc | 2020-12-03 | 10 percent owner |
2020-06-30 | 10 percent owner | ||
2020-06-25 | 10 percent owner | ||
2020-06-23 | 10 percent owner | ||
2020-05-05 | 10 percent owner | ||
2020-04-02 | director & 10 percent owner | ||
2021-03-11 | 10 percent owner | ||
2022-12-09 | 10 percent owner | ||
2022-05-26 | director & 10 percent owner | ||
2021-03-15 | 10 percent owner | ||
2020-01-23 | 10 percent owner | ||
2021-02-26 | director & 10 percent owner | ||
2018-10-23 | 10 percent owner | ||
2018-10-01 | 10 percent owner | ||
2018-06-22 | 10 percent owner | ||
2017-12-18 | 10 percent owner | ||
2017-05-22 | 10 percent owner | ||
2016-11-21 | 10 percent owner | ||
2015-10-22 | 10 percent owner | ||
2023-12-11 | 10 percent owner | ||
2014-09-29 | other: Former 10% Owner & See FN(5)(6) | ||
2013-06-26 | 10 percent owner | ||
2014-01-10 | other: Fmr 10% Owner - See Fn (1)-(5) | ||
2010-02-26 | 10 percent owner | ||
2008-10-29 | 10 percent owner | ||
2008-07-10 | 10 percent owner | ||
2007-08-08 | 10 percent owner | ||
2021-08-03 | 10 percent owner | ||
2023-07-21 | director & 10 percent owner | ||
2020-12-07 | 10 percent owner | ||
2023-03-30 | director & 10 percent owner | ||
2020-11-22 | 10 percent owner | ||
2024-01-11 | director & 10 percent owner | ||
2020-09-24 | 10 percent owner | ||
2024-06-27 | director & 10 percent owner | ||
2023-01-06 | director & 10 percent owner | ||
2022-03-29 | director & 10 percent owner | ||
2024-03-27 | 10 percent owner | ||
2024-06-17 | director & 10 percent owner | ||
2021-04-01 | 10 percent owner | ||
2021-06-23 | director | ||
2021-02-09 | director & 10 percent owner | ||
2023-07-19 | director & 10 percent owner | ||
2022-03-11 | director | ||
2024-02-09 | director & 10 percent owner | ||
2021-09-17 | director & 10 percent owner | ||
2023-08-18 | 10 percent owner | ||
2023-01-20 | 10 percent owner | ||
2022-11-08 | director | ||
2022-11-17 | director & 10 percent owner | ||
2024-03-27 | director | ||
2020-03-11 | 10 percent owner | ||
2023-02-14 | director & 10 percent owner | ||
2023-07-05 | director |
Ra Capital Healthcare Fund Lp Latest Holdings Summary
Ra Capital Healthcare Fund Lp currently owns a total of 42 stocks. Among these stocks, Ra Capital Healthcare Fund Lp owns 14,903,741 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $1.0 Billion and a weighting of 29.33%. Ra Capital Healthcare Fund Lp owns 5,001,593 shares of Vaxcyte Inc (PCVX) as of October 8, 2020, with a value of $381 Million and a weighting of 11.04%. Ra Capital Healthcare Fund Lp also owns 9,165,652 shares of Janux Therapeutics Inc (JANX) as of July 19, 2023, with a value of $353 Million and a weighting of 10.21%. The other 39 stocks Eidos Therapeutics Inc (EIDX) , Ra Pharmaceuticals Inc (RARX) , Forma Therapeutics Holdings Inc (FMTX) , Rhythm Pharmaceuticals Inc (RYTM) , WAVE Life Sciences Ltd (WVE) , Icosavax Inc (ICVX) , Achillion Pharmaceuticals Inc (ACHN) , Arvinas Inc (ARVN) , Fulcrum Therapeutics Inc (FULC) , Cytek Biosciences Inc (CTKB) , DICE Therapeutics Inc (DICE) , Acumen Pharmaceuticals Inc (ABOS) , Phathom Pharmaceuticals Inc (PHAT) , Akouos Inc (AKUS) , Solid Biosciences Inc (SLDB) , LENZ Therapeutics Inc (LENZ) , Imara Inc (IMRA) , G1 Therapeutics Inc (GTHX) , Orchard Therapeutics PLC (ORTX) , Mineralys Therapeutics Inc (MLYS) , Black Diamond Therapeutics Inc (BDTX) , AN2 Therapeutics Inc (ANTX) , scPharmaceuticals Inc (SCPH) , Therapeutics Acquisition Corp (RACA) , ARS Pharmaceuticals Inc (SPRY) , Tyra Biosciences Inc (TYRA) , Elevance Health Inc (ANTX) , Eliem Therapeutics Inc (ELYM) , Satsuma Pharmaceuticals Inc (STSA) , Nkarta Inc (NKTX) , Verastem Inc (VSTM) , PepGen Inc (PEPG) , Acrivon Therapeutics Inc (ACRV) , 89bio Inc (ETNB) , Vor Biopharma Inc (VOR) , Boundless Bio Inc (BOLD) , Kala Bio Inc (KALA) , Werewolf Therapeutics Inc (HOWL) , Aerovate Therapeutics Inc (AVTE) have a combined weighting of 49.42% among all his current holdings.
Latest Holdings of Ra Capital Healthcare Fund Lp
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
THOR | Synthorx Inc | 2018-12-11 | 14,903,741 | 67.99 | 1,013,305,351 |
PCVX | Vaxcyte Inc | 2020-10-08 | 5,001,593 | 76.26 | 381,421,482 |
JANX | Janux Therapeutics Inc | 2023-07-19 | 9,165,652 | 38.50 | 352,877,602 |
EIDX | Eidos Therapeutics Inc | 2018-06-22 | 2,162,671 | 122.21 | 264,300,023 |
RARX | Ra Pharmaceuticals Inc | 2018-12-12 | 4,858,260 | 47.99 | 233,147,897 |
FMTX | Forma Therapeutics Holdings Inc | 2020-06-23 | 9,011,651 | 20.01 | 180,323,137 |
RYTM | Rhythm Pharmaceuticals Inc | 2020-12-03 | 4,360,860 | 40.81 | 177,966,697 |
WVE | WAVE Life Sciences Ltd | 2023-12-11 | 19,202,009 | 5.32 | 102,154,688 |
ICVX | Icosavax Inc | 2022-03-29 | 5,963,565 | 15.31 | 91,302,180 |
ACHN | Achillion Pharmaceuticals Inc | 2013-09-30 | 11,657,061 | 6.76 | 78,801,732 |
ARVN | Arvinas Inc | 2018-10-01 | 3,138,412 | 23.90 | 75,008,047 |
FULC | Fulcrum Therapeutics Inc | 2023-01-20 | 11,609,704 | 6.16 | 71,457,728 |
CTKB | Cytek Biosciences Inc | 2022-03-11 | 12,797,184 | 5.57 | 71,280,315 |
DICE | DICE Therapeutics Inc | 2023-03-30 | 786,407 | 47.55 | 37,393,653 |
ABOS | Acumen Pharmaceuticals Inc | 2023-07-21 | 13,632,029 | 2.37 | 32,307,909 |
PHAT | Phathom Pharmaceuticals Inc | 2021-03-11 | 3,115,008 | 10.25 | 31,928,832 |
AKUS | Akouos Inc | 2020-06-30 | 2,281,249 | 13.29 | 30,317,799 |
SLDB | Solid Biosciences Inc | 2024-01-11 | 4,301,877 | 5.97 | 25,682,206 |
LENZ | LENZ Therapeutics Inc | 2024-03-21 | 1,389,510 | 17.66 | 24,538,747 |
IMRA | Imara Inc | 2022-12-09 | 3,250,724 | 6.32 | 20,544,576 |
GTHX | G1 Therapeutics Inc | 2017-05-22 | 6,691,792 | 2.57 | 17,197,905 |
ORTX | Orchard Therapeutics PLC | 2020-09-24 | 988,087 | 16.70 | 16,501,053 |
MLYS | Mineralys Therapeutics Inc | 2023-02-14 | 1,311,247 | 12.15 | 15,931,651 |
BDTX | Black Diamond Therapeutics Inc | 2023-07-05 | 3,525,754 | 4.44 | 15,654,348 |
ANTX | AN2 Therapeutics Inc | 2023-08-18 | 5,551,295 | 2.71 | 15,044,009 |
SCPH | scPharmaceuticals Inc | 2021-03-15 | 2,727,446 | 4.25 | 11,591,646 |
RACA | Therapeutics Acquisition Corp | 2021-06-29 | 1,098,318 | 10.27 | 11,284,449 |
SPRY | ARS Pharmaceuticals Inc | 2024-03-27 | 902,904 | 9.09 | 8,207,397 |
TYRA | Tyra Biosciences Inc | 2021-09-17 | 442,721 | 16.97 | 7,512,975 |
ANTX | Elevance Health Inc | 2022-03-29 | 415,612 | 15.84 | 6,583,294 |
ELYM | Eliem Therapeutics Inc | 2024-06-27 | 841,087 | 6.86 | 5,769,857 |
STSA | Satsuma Pharmaceuticals Inc | 2021-02-26 | 5,155,854 | 1.10 | 5,671,439 |
NKTX | Nkarta Inc | 2024-03-27 | 754,311 | 5.36 | 4,039,335 |
VSTM | Verastem Inc | 2020-06-25 | 1,345,170 | 2.94 | 3,954,800 |
PEPG | PepGen Inc | 2024-02-09 | 207,672 | 16.68 | 3,463,969 |
ACRV | Acrivon Therapeutics Inc | 2022-11-17 | 426,302 | 6.14 | 2,617,494 |
ETNB | 89bio Inc | 2024-03-04 | 335,364 | 7.48 | 2,508,523 |
VOR | Vor Biopharma Inc | 2021-02-09 | 1,825,326 | 0.92 | 1,679,300 |
BOLD | Boundless Bio Inc | 2024-04-02 | 295,844 | 4.24 | 1,254,379 |
KALA | Kala Bio Inc | 2022-05-26 | 140,792 | 6.82 | 960,201 |
HOWL | Werewolf Therapeutics Inc | 2023-01-06 | 443,825 | 2.14 | 949,786 |
AVTE | Aerovate Therapeutics Inc | 2024-06-17 | 311,170 | 1.69 | 525,877 |
Holding Weightings of Ra Capital Healthcare Fund Lp
Ra Capital Healthcare Fund Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 4,545,455 shares on December 11, 2018, which cost Ra Capital Healthcare Fund Lp around $50 Million.
According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 2 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Vaxcyte Inc is the sale of 266,258 shares on October 8, 2020, which brought Ra Capital Healthcare Fund Lp around $14 Million.
According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 1 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Janux Therapeutics Inc is the acquisition of 495,008 shares on July 19, 2023, which cost Ra Capital Healthcare Fund Lp around $6 Million.
More details on Ra Capital Healthcare Fund Lp's insider transactions can be found in the Insider Trading History of Ra Capital Healthcare Fund Lp table.Insider Trading History of Ra Capital Healthcare Fund Lp
- 1
Ra Capital Healthcare Fund Lp Trading Performance
GuruFocus tracks the stock performance after each of Ra Capital Healthcare Fund Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ra Capital Healthcare Fund Lp is 3.44%. GuruFocus also compares Ra Capital Healthcare Fund Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ra Capital Healthcare Fund Lp within 3 months outperforms 34 times out of 77 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ra Capital Healthcare Fund Lp's insider trading performs compared to the benchmark.
Performance of Ra Capital Healthcare Fund Lp
Ra Capital Healthcare Fund Lp Ownership Network
Ownership Network List of Ra Capital Healthcare Fund Lp
Ownership Network Relation of Ra Capital Healthcare Fund Lp
Ra Capital Healthcare Fund Lp Owned Company Details
What does Vaxcyte Inc do?
Who are the key executives at Vaxcyte Inc?
Ra Capital Healthcare Fund Lp is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include SVP & Gen Counsel & Corp Sec Mikhail Eydelman , Chief Operating Officer Jim Wassil , and director & President & CEO Grant Pickering .
Vaxcyte Inc (PCVX) Insider Trades Summary
Over the past 18 months, Ra Capital Healthcare Fund Lp made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 158,552 shares made by Grant Pickering , a net sale of 86,000 shares made by Andrew Guggenhime , and a net sale of 27,000 shares made by Jim Wassil .
In summary, during the past 3 months, insiders sold 106,433 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 106,433 shares. During the past 18 months, 349,080 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 349,080 shares.
Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vaxcyte Inc Insider Transactions
Ra Capital Healthcare Fund Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Ra Capital Healthcare Fund Lp. You might contact Ra Capital Healthcare Fund Lp via mailing address: 200 Berkeley Street, 18th Floor, Boston Ma 02116.